Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22 modified FK520 analog against C. neoformans
A. Rivera, W. Lim, E. Park, P. A. Dome, M. J. Hoy, I. Spasojevic, S. Sun, A. Floyd Averette, S. Pina-Oviedo, P. R. Juvvadi, W. J. Steinbach, M. Ciofani, J. Hong, J. Heitman
This paper identifies a modified FK520 analog, JH-FK-08, with reduced immunosuppression and improved antifungal efficacy against C. neoformans in vivo.
bioRxiv · Jun 5, 2023Microbiology